Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric M Rohren

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Clinical Nuclear Medicine|February 2, 2016
Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra TherapyElba C Etchebehere, John C Araujo, Denái R Milton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancerUgo De Giorgi, Michal Mego, Eric M Rohren, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 24, 2013
(18)F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapySelin Carkaci, Christopher T Sherman, Efe Ozkan, et al.
Medical Physics|October 8, 2011
Investigating the limit of detectability of a positron emission mammography device: a phantom studyNicholas A Shkumat, Adam Springer, Christopher M Walker, et al.
The Lancet. Oncology|June 2, 2009
Imaging bone metastases in breast cancer: techniques and recommendations for diagnosisColleen M Costelloe, Eric M Rohren, John E Madewell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2015
American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: BrainHossein Jadvar, Rathan M Subramaniam, Claudia G Berman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2017
ACR and SNMMI Joint Credentialing Statement for PET/MRI of the BodyRathan M Subramaniam, Hossein Jadvar, Patrick M Colletti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2009
18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcomaColleen M Costelloe, Homer A Macapinlac, John E Madewell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple MyelomaSikander Ailawadhi, Rachael Sexton, Suzanne Lentzsch, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 5, 2014
Measuring the extent of total thyroidectomy for differentiated thyroid carcinoma using radioactive iodine imaging: relationship with serum thyroglobulin and clinical outcomesF Christopher Holsinger, Uma Ramaswamy, Maria E Cabanillas, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Clinical Nuclear Medicine|February 2, 2016
Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra TherapyElba C Etchebehere, John C Araujo, Denái R Milton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancerUgo De Giorgi, Michal Mego, Eric M Rohren, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 24, 2013
(18)F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapySelin Carkaci, Christopher T Sherman, Efe Ozkan, et al.
Medical Physics|October 8, 2011
Investigating the limit of detectability of a positron emission mammography device: a phantom studyNicholas A Shkumat, Adam Springer, Christopher M Walker, et al.
The Lancet. Oncology|June 2, 2009
Imaging bone metastases in breast cancer: techniques and recommendations for diagnosisColleen M Costelloe, Eric M Rohren, John E Madewell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2015
American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: BrainHossein Jadvar, Rathan M Subramaniam, Claudia G Berman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2017
ACR and SNMMI Joint Credentialing Statement for PET/MRI of the BodyRathan M Subramaniam, Hossein Jadvar, Patrick M Colletti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2009
18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcomaColleen M Costelloe, Homer A Macapinlac, John E Madewell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple MyelomaSikander Ailawadhi, Rachael Sexton, Suzanne Lentzsch, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 5, 2014
Measuring the extent of total thyroidectomy for differentiated thyroid carcinoma using radioactive iodine imaging: relationship with serum thyroglobulin and clinical outcomesF Christopher Holsinger, Uma Ramaswamy, Maria E Cabanillas, et al.
Pageof 8